Guidance Needed To Explain Scope Of MDR’s Confusing Clinical Investigations Clause
Executive Summary
Article 61(5) of the EU’s Medical Device Regulation gives certain manufacturers an exemption from having to perform clinical investigations by demonstrating equivalence to other companies’ products. But to whom does it apply and who could actually make use of it? Dr. Maria Donawa explains why clarification is urgently needed.
You may also be interested in...
Notified Body Pain Points: The Challenges And Obstacles Industry Needs To Avoid
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
Long-Awaited EU IVD Classification Guidance Just Published: Initial Reactions
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Making The Leap From EU MDD To MDR Clinical Evidence (Part 3): Critical Questions Answered
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: